Increased Urine IgM and IgG(2) Levels, Indicating Decreased Glomerular Size Selectivity, Are Not Affected by Dalteparin Therapy in Patients with Type 2 Diabetes

Por Torffvit, Ole, Kalani, Majid, Apelqvist, Jan, Eliasson, Björn, Eriksson, Jan W., Brismar, Kerstin, Jörneskog, Gun
Publicado em 2012

Dapagliflozin once‐daily and exenatide once‐weekly dual therapy: A 24‐week randomized, placebo‐controlled, phase II study examining effects on body weight and prediabetes in obese...

Por Lundkvist, Per, Sjöström, C. David, Amini, Sam, Pereira, Maria J., Johnsson, Eva, Eriksson, Jan W.
Publicado no Diabetes Obes Metab (2016)

A randomised wait-list controlled clinical trial of the effects of acceptance and commitment therapy in patients with type 1 diabetes: a study protocol

Por Lindholm-Olinder, Anna, Fischier, Johan, Fries, Jenny, Alfonsson, Sven, Elvingson, Veronika, Eriksson, Jan W, Leksell, Janeth
Publicado no BMC Nurs (2015)

Signs of dysregulated fibrinolysis precede the development of type 2 diabetes mellitus in a population-based study

Por Hernestål-Boman, Jenny, Norberg, Margareta, Jansson, Jan-Hakan, Eliasson, Mats, Eriksson, Jan W, Lindahl, Bernt, Johansson, Lars
Publicado em 2012

Alterations in heart rate variability during everyday life are linked to insulin resistance. A role of dominating sympathetic over parasympathetic nerve activity?

Por Svensson, Maria K., Lindmark, Stina, Wiklund, Urban, Rask, Peter, Karlsson, Marcus, Myrin, Jan, Kullberg, Joel, Johansson, Lars, Eriksson, Jan W.
Publicado no Cardiovasc Diabetol (2016)

Evaluation of reference genes for gene expression studies in human brown adipose tissue

Por Taube, Magdalena, Andersson-Assarsson, Johanna C, Lindberg, Kristin, Pereira, Maria J, Gäbel, Markus, Svensson, Maria K, Eriksson, Jan W, Svensson, Per-Arne
Publicado no Adipocyte (2015)

A 24-WEEK, MULTICENTER, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE CHANGES IN GLUCOSE METABOLISM IN PATIENTS WITH SCHIZOPHRENIA RECEIVING TREATMENT WITH OLANZAPINE, QUETIAPINE AND RIS...

Por Newcomer, John W., Ratner, Robert E., Eriksson, Jan W., Emsley, Robin, Meulien, Didier, Miller, Frank, Leonova-Edlund, Julia, Leong, Ronald W, Brecher, Martin
Publicado em 2009

Role of cannabinoid receptor 1 in human adipose tissue for lipolysis regulation and insulin resistance

Por Sidibeh, Cherno O., Pereira, Maria J., Lau Börjesson, Joey, Kamble, Prasad G., Skrtic, Stanko, Katsogiannos, Petros, Sundbom, Magnus, Svensson, Maria K., Eriksson, Jan W.
Publicado no Endocrine (2016)

DGAT1 deficiency decreases PPAR expression and does not lead to lipotoxicity in cardiac and skeletal muscle

Por Liu, Li, Yu, Shuiqing, Khan, Raffay S., Ables, Gene P., Bharadwaj, Kalyani G., Hu, Yunying, Huggins, Lesley A., Eriksson, Jan W., Buckett, Linda K., Turnbull, Andrew V., Ginsberg, Henry N., Blaner, William S., Huang, Li-Shin, Goldberg, Ira J.
Publicado em 2011

Cardiomyocyte-specific Loss of Diacylglycerol Acyltransferase 1 (DGAT1) Reproduces the Abnormalities in Lipids Found in Severe Heart Failure

Por Liu, Li, Trent, Chad M., Fang, Xiang, Son, Ni-Huiping, Jiang, HongFeng, Blaner, William S., Hu, Yunying, Yin, Yu-Xin, Farese, Robert V., Homma, Shunichi, Turnbull, Andrew V., Eriksson, Jan W., Hu, Shi-Lian, Ginsberg, Henry N., Huang, Li-Shin, Goldberg, Ira J.
Publicado em 2014